Publication:
Evaluation of inner and outer retinal thickness in patients receiving intravitreal ranibizumab injections for diabetic macular edema

dc.contributor.authorDURSUN, AYHAN
dc.contributor.authorOzec, Ayse Vural
dc.contributor.authorKirboga, Kadir
dc.contributor.authorDURSUN, Feyza Gulac
dc.contributor.authorTOKER, MUSTAFA İLKER
dc.contributor.authorERDOĞAN, HAYDAR
dc.contributor.authorARICI, MUSTAFA KEMAL
dc.contributor.institutionauthorARICI, MUSTAFA KEMAL
dc.date.accessioned2020-10-29T23:10:53Z
dc.date.available2020-10-29T23:10:53Z
dc.date.issued2016-01-01T00:00:00Z
dc.description.abstractPurpose: To measure inner and outer retinal thickness with optical coherence tomography (OCT) in patients in whom intravitreal ranibizumab was administered due to diabetic macular edema (DME) and to investigate its relation to the visual prognosis.
dc.identifier.citationDURSUN A., Ozec A. V. , Kirboga K., DURSUN F. G. , TOKER M. İ. , ERDOĞAN H., ARICI M. K. , -Evaluation of inner and outer retinal thickness in patients receiving intravitreal ranibizumab injections for diabetic macular edema-, EUROPEAN JOURNAL OF OPHTHALMOLOGY, cilt.26, ss.48-53, 2016
dc.identifier.doi10.5301/ejo.5000655
dc.identifier.scopus84954058003
dc.identifier.urihttp://hdl.handle.net/20.500.12645/26929
dc.identifier.wosWOS:000372258400009
dc.titleEvaluation of inner and outer retinal thickness in patients receiving intravitreal ranibizumab injections for diabetic macular edema
dc.typeArticle
dspace.entity.typePublication
local.avesis.idd4500c5e-3517-4c78-81c9-68fbb114b427
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublicationb4f16291-c061-4519-b1b5-a0021be32879
relation.isAuthorOfPublication.latestForDiscoveryb4f16291-c061-4519-b1b5-a0021be32879
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files
Collections